Skye Bioscience, Inc. (SKYE)
NCM · Biotechnology
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. is headquartered in San Diego, California.
Peers in Biotechnology
All in industry →Vertex Pharmaceuticals Incorporated
Regeneron Pharmaceuticals, Inc.
argenx SE
Alnylam Pharmaceuticals, Inc.
BeOne Medicines AG
Insmed Incorporated
Royalty Pharma plc
BioNTech SE
Roivant Sciences Ltd.
Moderna, Inc.
Recent press releases
April 2026
Skye Bioscience, Inc. — PREM14A Filing
# 🧾 What This Document Is This is a **preliminary proxy statement (PRE14A)** for Skye Bioscience. Think of it as an invitation and information packet for the company's annual shareholder meeting. Its main job is to ask shareholders to vote on key proposals, like electing directors and approving com
Skye Bioscience, Inc. — PRE 14A Filing
Here's a clear breakdown of Skye Bioscience's PRE 14A filing: # 🧾 What This Document Is This is a **preliminary proxy statement** for Skye Bioscience's 2026 Annual Shareholder Meeting. It outlines proposals shareholders will vote on and provides essential company information. Think of it as the ag
Skye Bioscience, Inc. — 8-K Filing
# 🧾 What This Document Is This is an **8-K filing**, which is a report public companies file with the SEC to announce major events that shareholders should know about. In this case, Skye Bioscience is reporting that it has entered into a **Master Services Agreement** with a consulting firm called *
SEC filings
All filings →Insider trades
All insider trades →Skye Bioscience, Inc. has no reported insider trades in the last 90 days.